Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
TDP-43 Proteinopathy Specific Biomarker Development
View through CrossRef
TDP-43 is the primary or secondary pathological hallmark of neurodegenerative diseases, such as amyotrophic lateral sclerosis, half of frontotemporal dementia cases, and limbic age-related TDP-43 encephalopathy, which clinically resembles Alzheimer’s dementia. In such diseases, a biomarker that can detect TDP-43 proteinopathy in life would help to stratify patients according to their definite diagnosis of pathology, rather than in clinical subgroups of uncertain pathology. For therapies developed to target pathological proteins that cause the disease a biomarker to detect and track the underlying pathology would greatly enhance such undertakings. This article reviews the latest developments and outlooks of deriving TDP-43-specific biomarkers from the pathophysiological processes involved in the development of TDP-43 proteinopathy and studies using biosamples from clinical entities associated with TDP-43 pathology to investigate biomarker candidates.
Title: TDP-43 Proteinopathy Specific Biomarker Development
Description:
TDP-43 is the primary or secondary pathological hallmark of neurodegenerative diseases, such as amyotrophic lateral sclerosis, half of frontotemporal dementia cases, and limbic age-related TDP-43 encephalopathy, which clinically resembles Alzheimer’s dementia.
In such diseases, a biomarker that can detect TDP-43 proteinopathy in life would help to stratify patients according to their definite diagnosis of pathology, rather than in clinical subgroups of uncertain pathology.
For therapies developed to target pathological proteins that cause the disease a biomarker to detect and track the underlying pathology would greatly enhance such undertakings.
This article reviews the latest developments and outlooks of deriving TDP-43-specific biomarkers from the pathophysiological processes involved in the development of TDP-43 proteinopathy and studies using biosamples from clinical entities associated with TDP-43 pathology to investigate biomarker candidates.
Related Results
Skin TDP-43 pathology as a candidate biomarker for predicting amyotrophic lateral sclerosis decades prior to motor symptom onset
Skin TDP-43 pathology as a candidate biomarker for predicting amyotrophic lateral sclerosis decades prior to motor symptom onset
Abstract
The recognition that disease-associated proteinopathies can manifest in peripheral organs outside the central nervous system preceding the onset of neurologica...
Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration
Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration
Abstract
TDP-43 is mislocalized from the nucleus and aggregates within the cytoplasm of affected neurons in cases of amyotrophic lateral sclerosis. TDP-43 pathology ...
In silico
and
in vitro
studies suggest epigallocatechin gallate (EGCG), a polyphenol in green tea, can bind and modulate the aggregation and cytotoxicity of the full-length TDP-43 protein implicated in
In silico
and
in vitro
studies suggest epigallocatechin gallate (EGCG), a polyphenol in green tea, can bind and modulate the aggregation and cytotoxicity of the full-length TDP-43 protein implicated in
ABSTRACT
Misfolding and aggregation of TDP-43 protein are implicated in several proteinopathies like ALS and FTLD. Extracellular TDP-43 is also p...
RNA-deficient TDP-43 causes loss of free nuclear TDP-43 by sequestration
RNA-deficient TDP-43 causes loss of free nuclear TDP-43 by sequestration
Abstract
Dysfunction and aggregation of the RNA-binding protein, TDP-43, is the unifying hallmark of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia...
Computational Insights Into the Mechanism of EGCG's Binding and Inhibition of the TDP‐43 Aggregation
Computational Insights Into the Mechanism of EGCG's Binding and Inhibition of the TDP‐43 Aggregation
ABSTRACTMisfolding and aggregation of TAR DNA‐binding protein, TDP‐43, is linked to devastating proteinopathies such as ALS. Therefore, targeting TDP‐43's aggregation is significan...
Science AMA Series: Hi, I’m Jonathan Ling, a researcher that’s here to share our new breakthrough discovery for ALS (amyotrophic lateral sclerosis)
Science AMA Series: Hi, I’m Jonathan Ling, a researcher that’s here to share our new breakthrough discovery for ALS (amyotrophic lateral sclerosis)
Hey reddit, Today, in the journal Science, you can find our paper which
describes the function of TDP-43, an important protein in ALS (the
disease that the ice bucket challenge rai...
Prion-like C-terminal domain of TDP-43 and α-Synuclein interact synergistically to generate neurotoxic hybrid fibrils
Prion-like C-terminal domain of TDP-43 and α-Synuclein interact synergistically to generate neurotoxic hybrid fibrils
ABSTRACT
Aberrant aggregation and amyloid formation of tar DNA binding protein (TDP-43) and α-synuclein (αS) underlie frontotemporal dementia (FTD) and Parkinson’s ...
TDP-43 Controls HIV-1 Viral Production and Virus Infectiveness
TDP-43 Controls HIV-1 Viral Production and Virus Infectiveness
The transactive response DNA-binding protein (TARDBP/TDP-43) is known to stabilize the anti-HIV-1 factor, histone deacetylase 6 (HDAC6). TDP-43 has been reported to determine cell ...